Medtronic Plc
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Geoffrey Straub Martha
- Full Time Employees
- 95,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Building Two, Parkmore Business Park West Galway GA Ireland H91 4K49
- IPO Date
- May 2, 1973
- CIK
- 0001613103
- Website
- medtronic.com
- Similar Companies
- Business
- Medtronic plc (NYSE: MDT) develops, manufactures, and markets a wide range of medical devices and therapies for the treatment of chronic diseases worldwide. The company offers products across four main segments: cardiovascular (including pacemakers, defibrillators, heart valves, and coronary stents under brands such as Evera, Protecta, and CoreValve); medical surgical (featuring surgical navigation systems, endoscopic tools, and stapling devices like Hugo RAS and Valiant NaviCore); neuroscience (encompassing spinal cord stimulators, deep brain stimulation systems, and intrathecal drug delivery pumps such as Incepta and SynchroMed II); and diabetes (primarily continuous glucose monitoring systems, insulin pumps, and related software through the MiniMed and Guardian brands). Medtronic provides services including patient management software, remote monitoring platforms, and clinical decision support tools to healthcare providers, hospitals, clinics, and patients globally. Founded in 1949 and headquartered in Dublin, Ireland, with principal executive offices in Minneapolis, Minnesota, USA, Medtronic operates in more than 150 countries, serving markets in North America, Europe, Asia-Pacific, Latin America, and the Middle East through direct sales forces, distributors, and subsidiaries. The company targets physicians, hospitals, ambulatory surgery centers, and home care settings, with a focus on minimally invasive therapies and digital health solutions. Key subsidiaries include Covidien (acquired in 2015 for surgical and patient monitoring products) and Intersect ENT (recently integrated for sinus implants). In the past 1-2 years, Medtronic has pursued strategic expansions including the FDA approval and U.S. launch of the Hugo robotic-assisted surgery (RAS) system in 2024 for soft tissue indications, building on its European CE Mark; a multi-year collaboration with NVIDIA announced in 2024 to advance AI-enabled therapies using Medtronic's Gigamon data platform; and the acquisition of Mazor Robotics in 2018 followed by ongoing enhancements to its spinal robotics portfolio with the Mazor X Stealth Edition. The company completed a $4.1 billion acquisition of Covidien assets integration and reported expansions in diabetes care via the Simplera Sync sensor FDA clearance in 2024. Medtronic also announced organizational realignments in 2025 to streamline its four operating units amid portfolio optimization efforts.
Company News
Medtronic (NYSE:MDT) Stock: Insider Geoffrey Martha Sells 50,000 Shares
How Many Shares Would It Take to Earn $1,000 a Year From This Future Dividend King?
Is it Apt to Retain Medtronic Stock in Your Portfolio Now?
Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable
Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Also Reward Patience
3 Overlooked Healthcare Dividend Stocks That Could Keep Paying for Decades
Medtronic Completes Separation of MiniMed Group, Inc.
MiniMed Completes Separation from Medtronic
7,240 Medtronic PLC $MDT Shares Acquired by Krilogy Financial LLC
Medtronic Pays More Today. Abbott Raises Its Dividend Faster.
Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer
Medtronic PLC $MDT Shares Bought by Allied Investment Advisors LLC
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse
13,074 Medtronic PLC $MDT Shares Acquired by NorthCrest Asset Manangement LLC
Medtronic (NYSE:MDT) Shares Climb 4.1% – Should You Buy?
Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer
Medtronic Is Just 1 Year From Dividend King Status. Should You Buy the Stock Before It Gets There?
The Monopolistic Razor-and-Blade Engine I Can’t Stop Buying
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields